Clinatec endowment fund hires new neuroillumination researchers

The Clinatec endowment fund has earned the support of several patrons, including the Covea mutual insurance company, since 2020. Today, the team is growing and research on infrared illumination therapy is intensifying. Australian scientist John Mitrofanis, internationally renowned for his work on neurodegenerative diseases and infrared light, was hired, building on a collaboration with Clinatec that began in 2015. In March, a clinical trial of the effects of neuroillumination on Parkinson’s disease began.
A first patient was implanted with a CEA-developed neuroillumination probe for the trial. The endowment fund is also expanding into Alzheimer’s and other neurodegenerative diseases.
Finally, an international advisor, Dr. Pierre Magistretti from Switzerland, has also been hired.

Contact: thierry.bosc@clinatec.fr